• Hyundai Bioscience leads in the repurposing of Niclosamide prnasia
    April 09, 2021
    A research paper by a South Korean bio tech company that demonstrated the drug repurposing of Niclosamide, an anthelmintic known to have excellent therapeutic efficacy against novel coronavirus infection (COVID-19), was published in the world-renowned ...
PharmaSources Customer Service